Which medication would the nurse associate to the treatment of a patient with hyponatremia secondary to heart failure?

Show

  • Which medication would the nurse associate to the treatment of a patient with hyponatremia secondary to heart failure?
    Access through your institution

Which medication would the nurse associate to the treatment of a patient with hyponatremia secondary to heart failure?

Which medication would the nurse associate to the treatment of a patient with hyponatremia secondary to heart failure?

Abstract

Patients with heart failure (HF) are at risk of developing hyponatremia due to retention of fluids which dilutes serum sodium. Studies have demonstrated that health care professionals have inadequate knowledge of managing hyponatremia in patients with HF. We created a mnemonic that provides nurse practitioners with an evidence-based approach to managing hyponatremia in HF. The “FIRST” mnemonic features 5 different treatment options: Fluid restriction, Induced diuresis, Received no specific treatment for hyponatremia, Saline (isotonic and hypertonic), and Tolvaptan.

Section snippets

Pathophysiology of Hyponatremia in Heart Failure

Heart failure (HF) is a clinical diagnosis characterized by insufficient cardiac output producing functional limitations, fluid overload, and an inability to meet the metabolic needs of the body.1 As a result of severe fluid retention, dilutional hyponatremia is a common and severe concern for the patient with HF.2 Hyponatremia develops in approximately 10% to 30% of hospitalized patients with HF.3 A systematic review and meta-analysis by Corona et al4 established that hyponatremia was

Background

A cohort study conducted by Miller et al15 explored the knowledge and understanding of Canadian health care professionals regarding management of hyponatremia in patients with HF. Miller et al15 established that only 69% of study participants identified the proper pathophysiology, 44% managed hyponatremia inadequately, and 61% of the participants selected the wrong sodium correction rate. The results of this study confirm the presence of a knowledge gap; thus, health care professionals, such as

F—Fluid Restriction

The Canadian Cardiovascular Society guidelines recommend a fluid restriction of 2 L/d for patients with HF who struggle with congestive symptoms.18 However, for patients with HF with hyponatremia, the Canadian Cardiovascular Society recommends a fluid restriction of ≤ 1.5 L/d.18 In addition, the American Heart Association established that fluid restriction is an appropriate and beneficial intervention for hyponatremia in heart failure.19 Many scholars state that a rapid increase in weight of 2

Conclusion

The mnemonic presented is a helpful tool for clinicians to recall and apply guideline-driven medical interventions to manage patient with hyponatremia in the context of HF. Early identification of hyponatremia and appropriate choice of treatment by the NP will result in favorable patient outcomes and decreased hospital length of stay. We provided a scientific comparison of the treatment options, including their benefits and drawbacks. The FIRST acronym organizes thought and provides NPs with a

Mohamed Toufic El Hussein, PhD, NP, is an associate professor, School of Nursing and Midwifery, Mount Royal University, Calgary; an adjunct associate professor, Faculty of Nursing, University of Calgary; and NP in the Cardiology Critical Care Unit at Alberta Health Services Rockyview Hospital, Calgary, Alberta, Canada, and can be contacted at [email protected].

References (34)

  • et al.

    Efficacy and safety of oral conivaptan, a vasopressin-receptor antagonist, evaluated in a randomized, controlled trial in patients with euvolemic or hypervolemic hyponatremia

    Am J Med Sci

    (2009)

  • J.G. Verbalis et al.

    Tolvaptan and neurocognitive function in mild to moderate chronic hyponatremia: a randomized trial (INSIGHT)

    Am J Kidney Dis

    (2016)

  • B.L. Bennett et al.

    Wilderness Medical Society clinical practice guidelines for the management of exercise-associated hyponatremia: 2019 Update

    Wilderness Environ Med

    (2020)

  • B. Bikdeli et al.

    Intravenous fluids in acute decompensated heart failure

    JACC Heart Fail

    (2015)

  • M. Yamazoe et al.

    Incidence of hospital-acquired hyponatremia by the dose and type of diuretics among patients with acute heart failure and its association with long-term outcomes

    J Cardiol

    (2018)

  • P.K. Whelton et al.

    2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults

    J Am Coll Cardiol

    (2018)

  • A. Greenberg et al.

    Current treatment practice and outcomes. Report of the Hyponatremia Registry

    Kidney Int

    (2015)

  • J.J. Atherton et al.

    National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the prevention, detection, and management of heart failure in Australia 2018

    Heart Lung Circ

    (2018)

  • M.T. El Hussein et al.

    Mnemonic to assist in management of liver cirrhosis

    J Nurse Pract

    (2018)

  • F.H. Verbrugge et al.

    Hyponatremia in acute decompensated heart failure: depletion versus dilution

    J Am Coll Cardiol

    (2015)

  • J.G. Howlett et al.

    The Canadian Cardiovascular Society heart failure companion: bridging guidelines to your practice

    Can J Cardiol

    (2016)

  • M. Rodriguez et al.

    Hyponatremia in heart failure: pathogenesis and management

    Curr Cardiol Rev

    (2019)

  • G. Corona et al.

    The economic burden of hyponatremia: systematic review and meta-analysis

    Am J Med

    (2016)

  • J.G. Verbalis et al.

    Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations

    Am J Med

    (2013)

  • M. Tinawi

    Hyponatremia and hypernatremia: a practical guide to disorders of water balance

    Arch Intern Med Res

    (2020)

  • R. Dineen et al.

    Hyponatremia-presentations and management

    Clin Med (Lond)

    (2017)

  • M.A. Buffington et al.

    Hyponatremia: a review

    J Intensive Care Med

    (2016)

  • Cited by (0)

    Mohamed Toufic El Hussein, PhD, NP, is an associate professor, School of Nursing and Midwifery, Mount Royal University, Calgary; an adjunct associate professor, Faculty of Nursing, University of Calgary; and NP in the Cardiology Critical Care Unit at Alberta Health Services Rockyview Hospital, Calgary, Alberta, Canada, and can be contacted at [email protected].

    Shani Markus and Sara Piedrahita are students in the BN program at Mount Royal University, Calgary, Alberta, Canada.

    View full text

    © 2020 Elsevier Inc. All rights reserved.

    Which medication would the nurse administer to counter the signs of toxicity when infusing magnesium sulphate IV to a patient with preeclampsia?

    Calcium gluconate: the antidote for magnesium toxicity is calcium gluconate 1 g IV over 3 minutes. Repeat doses may be necessary. Calcium chloride can also be used in lieu of calcium gluconate. The suggested dose for calcium chloride for magnesium toxicity is 500 mg of 10% calcium chloride IV given over 5-10 minutes.

    Which nursing intervention is most appropriate when caring for a client with dehydration?

    Administer intravenous hydration if needed. Severely dehydrated patients or patients unable to take oral hydration may require IV hydration to maintain appropriate hydration level.

    Which is a priority nursing action when providing care to a patient who is being treated for Hypernatremia that developed slowly over several days?

    The answer is D: Give slowly and watch for signs and symptoms of cerebral edema. The most important intervention is to give slowly and watch for S&S of cerebral edema because a hypotonic solution can cause rapid swelling of the cell. Maintain a patent IV is correct but not the most important option in this scenario.

    Which action will the nurse perform to ensure the patient safety when preparing to administer IV potassium chloride to a patient?

    Hands down, this is the most effective safeguard to prevent inadvertent IV administration of undiluted potassium chloride.